Thus, it is apparent that KIT plays a critical role in cell proliferation and differentiation [24,25] and represents a logical therapeutic target in GIST, CML and other diseases [26]. Here, KIT is linked to chronic myelogenous leukemia, BCR-ABL1 positive.